01
Agentic AI Scientists
Autonomous LLM agents that reason across chemical space, orchestrate docking and MD pipelines, and design molecules with minimal human steering — the lab partner of the next decade.
Agentic AI · Foundation Models · Longevity
The next decade of drug discovery will be written by autonomous agents.
From 2026 to 2036, the Giri Pillai Lab is building agentic AI co-scientists, biology foundation models, and GPU-native chemistry that collapse the path from target to clinic — with longevity, rare disease, and global health at the centre.
"Great challenge in science is how to best incorporate the existing knowledge."
Giri Pillai Lab · Science for Society
10yr
Vision horizon 2026–2036
41
Peer-reviewed papers
15+
Years in discovery
2k+
Talks & training sessions
2026 — 2036 · A decade of agentic science
The technology shaping the next ten years
Three converging frontiers — autonomous AI agents, biology foundation models, and GPU/quantum-native chemistry — rewriting how medicines are discovered.
02
Foundation Models for Biology
Protein, molecule, and cell-state foundation models (AlphaFold-class, ESM, Boltz) fused with mechanistic ML to map disease biology and longevity targets at unprecedented scale.
03
Quantum & GPU-Native Chemistry
Diffusion-based generative chemistry, GPU-accelerated MD, and early quantum-assisted free-energy methods — compressing lead optimisation from years to weeks by 2030.
The 10-year roadmap
Milestones we're building toward — from today's agentic prototypes to autonomous, clinic-ready discovery by 2036.
- 2036Goal — autonomous discovery loops delivering clinic-ready candidates
- 2030Foundation-model-native SAR & longevity pipelines in routine use
- 2026Agentic AI co-scientists deployed across active discovery programmes
- NowLead Scientist, Sygnature Discovery — UK